Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Gerlach

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 2, 2024
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance studyJessica Riegger, Karin Maria Egberts, Hans-Willi Clement, et al.
Pharmaceutics|August 28, 2025
Sex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and AdolescentsMaike Scherf-Clavel, Stefanie Fekete, Manfred Gerlach, et al.
Pharmacopsychiatry|February 7, 2022
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical PracticeKarin M Egberts, Manfred Gerlach, Christoph U Correll, et al.
Comprehensive Psychiatry|March 6, 2022
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorderElvira Tini, Lukasz Smigielski, Marcel Romanos, et al.
Pharmaceutics|September 28, 2023
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL TrialMichael Frey, Lukasz Smigielski, Elvira Tini, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Neuroscience and Biobehavioral Reviews|February 7, 2021
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorderStephen V Faraone, Tobias Banaschewski, David Coghill, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 2, 2024
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance studyJessica Riegger, Karin Maria Egberts, Hans-Willi Clement, et al.
Pharmaceutics|August 28, 2025
Sex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and AdolescentsMaike Scherf-Clavel, Stefanie Fekete, Manfred Gerlach, et al.
Pharmacopsychiatry|February 7, 2022
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical PracticeKarin M Egberts, Manfred Gerlach, Christoph U Correll, et al.
Comprehensive Psychiatry|March 6, 2022
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorderElvira Tini, Lukasz Smigielski, Marcel Romanos, et al.
Pharmaceutics|September 28, 2023
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL TrialMichael Frey, Lukasz Smigielski, Elvira Tini, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Neuroscience and Biobehavioral Reviews|February 7, 2021
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorderStephen V Faraone, Tobias Banaschewski, David Coghill, et al.
Pageof 15